{
  "ptid_time": "133_S_0629_2006-07-19",
  "img_path": "/data/qiuhui/data/adni/images/133_S_0629/2006-07-19/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 79,350 mm³, 106.0% above the reference mean. With a Z-score of 2.54 (99.4th percentile), this represents significant enlargement; hippocampal volume measures 4,788 mm³, 36.7% below the reference mean. With a Z-score of -3.58 (0.0th percentile), this represents profound atrophy; whole brain volume measures 888,750 mm³, 17.7% below the reference mean. With a Z-score of -2.29 (1.1th percentile), this represents significant atrophy; entorhinal cortex volume measures 2,700 mm³, 34.2% below the reference mean. With a Z-score of -2.32 (1.0th percentile), this represents significant atrophy; fusiform gyrus volume measures 12,115 mm³, 35.7% below the reference mean. With a Z-score of -3.04 (0.1th percentile), this represents profound atrophy; middle temporal gyrus volume measures 17,274 mm³, 19.0% below the reference mean. With a Z-score of -1.71 (4.3th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 70.8 years. Gender is Male. Education: 20 years. Handedness: Right. Race: White. Medical history: Cardiovascular; Major Surgical Procedures. MMSE: 29.0. Logical Memory: 5.0. APOEε4 alleles: 2.0. ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows profound atrophy in the hippocampus, entorhinal cortex, and fusiform gyrus—key regions affected in Alzheimer's disease (AD). Ventricular enlargement and whole-brain atrophy further support neurodegeneration. However, the MMSE score of 29 is within the normal range, which is atypical for dementia at this stage of structural decline.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely prodromal Alzheimer’s given biomarker severity, but preserved function prevents dementia diagnosis).  \n\n**Confidence:** **Medium** (high confidence in neurodegeneration, but clinical-cognitive discordance lowers certainty in staging).  \n\n*Note:* APOE4 homozygosity (2 alleles) strongly increases AD risk, and the structural changes are severe enough to suggest imminent progression to dementia. Follow-up with CSF biomarkers (Aβ42, p-tau) or amyloid PET would clarify etiology.",
  "timestamp": "2025-07-26T15:22:08.427583"
}